To evaluate applications of highly purified recombinant EBV DNAase in the diagnosis and prognosis of NPC, we tested sera from patients with NPC, other EBV-associated diseases and EBV-seropositive and -seronegative healthy subjects by immunoblotting and DNAase inhibitory assay. The results were compa
Anti-EBV serologic tests for nasopharyngeal carcinoma
β Scribed by H. Bryan Neel III; Gary R. Pearson; Louis H. Weiland; William F. Taylor; Anne P. Lanier; Andrew T. Huang; Helmut H. Goeppert; Vincent J. Hyams; Ben Z. Pilch; Paul H. Levine; Gertrude Henle; Werner Henle
- Book ID
- 115040960
- Publisher
- John Wiley and Sons
- Year
- 1980
- Tongue
- English
- Weight
- 568 KB
- Volume
- 90
- Category
- Article
- ISSN
- 0023-852X
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract We assessed 5 EBV specific assays for their capacity to effect serologic diagnosis of suspected NPC. The assays were the immunofluorescent assays, VCA IgA and EA IgA, the enzymeβlinked immunosorbent assays specific for EBNA 1 IgA or zta IgG and an EBV DNA assay. Serum samples were taken
## Abstract A search was made for EpsteinβBARR virus (EBV) associated nuclear antigen (EBNA) in touch preparations of fresh biopsy material from 26 carcinomas of the nasopharynx, 39 other tumours of the head and neck, the nasopharyngeal mucosa of 32 patients in whom nasopharyngeal neoplasm had been